title: Unanswered Questions Regarding Optimal Pediatric Vancomycin Use.
authors.affiliation: *Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah†Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, Utah‡Academic Division of Child Health, Derbyshire Children's Hospital, Derby, United Kingdom.
authors.forename: Chris
authors.initials: C
authors.lastname: Stockmann
authors.forename: Helen
authors.initials: H
authors.lastname: Sammons
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Starkey
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Constance
authors.forename: Catherine M T
authors.initials: CM
authors.lastname: Sherwin
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D010372:Pediatrics; D013203:Staphylococcal Infections / Q000188:drug therapy; D014640:Vancomycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin